SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-043761
Filing Date
2024-05-15
Accepted
2024-05-15 17:05:19
Documents
14
Period of Report
2024-05-14
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0206133-8k_180lifesci.htm   iXBRL 8-K 42199
  Complete submission text file 0001213900-24-043761.txt   265482

Data Files

Seq Description Document Type Size
2 XBRL DEFINITION FILE atnf-20240514_def.xml EX-101.DEF 26629
3 XBRL LABEL FILE atnf-20240514_lab.xml EX-101.LAB 36680
4 XBRL PRESENTATION FILE atnf-20240514_pre.xml EX-101.PRE 25253
5 XBRL SCHEMA FILE atnf-20240514.xsd EX-101.SCH 3787
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0206133-8k_180lifesci_htm.xml XML 5806
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 24952401
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)